SUBSCRIBE
SUBSCRIBE
News   Business

Navidea Biopharmaceuticals Announces Fourth Quarter and Full-Year 2012 Results

March 7, 2013 | 
1 min read
Navidea Biopharmaceuticals, Inc. (NYSE MKT: NAVB), a biopharmaceutical company focused on precision diagnostic radiopharmaceuticals, today announced consolidated results for the fourth quarter of 2012 and for the year ended December 31, 2012.
Earnings
MORE ON THIS TOPIC
Podcast
Second Half Milestones, KalVista’s Surprise Approval, Another RFK Jr. Lawsuit, More
July 9, 2025
 · 
1 min read
 · 
Heather McKenzie
People are attracted to a profitable business. Corporation, joint venture. Fundraising. Fair distribution of income among team members. Development of funds, budget use. Investment groups. Corruption
Radiopharmaceuticals
Actithera Raises $75.5M To Play in Sizzling Radiopharma Space
July 9, 2025
 · 
2 min read
 · 
Tristan Manalac
Solution Concept with Handshake on Chalkboard Background
Mergers & acquisitions
Concentra Snags Another Struggling Biotech as Cargo Accepts $200M Buyout
July 8, 2025
 · 
1 min read
 · 
Annalee Armstrong
Robot and human hand in retro collage style with halftone. Vector illustration, artificial intelligence concept.
Artificial intelligence
Roche’s Chugai Breaks Into Aging via Potential $1B+ Deal With AI Outfit Gero
July 7, 2025
 · 
2 min read
 · 
Dan Samorodnitsky